Brief: Aarti Drugs Says In FY25, Anticipate Improvement In Margins Driven By Growth In Export Sales
26/07/2024 15:21
July 26 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* AARTI DRUGS - IN FY25, ANTICIPATE IMPROVEMENT IN MARGINS
DRIVEN
BY GROWTH IN EXPORT SALES
* AARTI DRUGS - ANTICIPATE TOTAL CAPEX OF 2 BILLION RUPEES
FOR
FY25
Further company coverage: ADRG.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees